Thrivent Financial for Lutherans’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Buy |
68,105
+329
| +0.5% | +$1.66K | ﹤0.01% | 2267 |
|
|
2025
Q1 | $439K | Sell |
67,776
-3,546
| -5% | -$23K | ﹤0.01% | 2123 |
|
|
2024
Q4 | $524K | Sell |
71,322
-570
| -0.8% | -$4.19K | ﹤0.01% | 2237 |
|
|
2024
Q3 | $538K | Sell |
71,892
-395
| -0.5% | -$2.96K | ﹤0.01% | 2225 |
|
|
2024
Q2 | $643K | Sell |
72,287
-2,401
| -3% | -$21.4K | ﹤0.01% | 2115 |
|
|
2024
Q1 | $757K | Sell |
74,688
-2,028
| -3% | -$20.6K | ﹤0.01% | 2046 |
|
|
2023
Q4 | $772K | Sell |
76,716
-1,884
| -2% | -$19K | ﹤0.01% | 2002 |
|
|
2023
Q3 | $736K | Buy |
78,600
+5,545
| +8% | +$51.9K | ﹤0.01% | 1927 |
|
|
2023
Q2 | $1.79M | Sell |
73,055
-2,139
| -3% | -$52.5K | ﹤0.01% | 1412 |
|
|
2023
Q1 | $1.75M | Sell |
75,194
-2,636
| -3% | -$61.3K | ﹤0.01% | 1392 |
|
|
2022
Q4 | $1.97M | Sell |
77,830
-323
| -0.4% | -$8.18K | 0.01% | 1273 |
|
|
2022
Q3 | $1.51M | Buy |
78,153
+5,323
| +7% | +$103K | ﹤0.01% | 1403 |
|
|
2022
Q2 | $1.86M | Buy |
+72,830
| New | +$1.86M | ﹤0.01% | 1266 |
|